Skip to main content
Top

2006 | OriginalPaper | Hoofdstuk

Is er een indicatie voor levenslange antistollingstherapie bij verlaagde (familiaire) antitrombine III-activiteit?

Auteurs : S. Middeldorp, Prof.Dr. E. Briët

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Antitrombine(voorheen antitrombine-III)-deficiëntie is een zeldzame risicofactor voor het krijgen van veneuze trombo-embolie met een prevalentie van 1 à 2% bij opeenvolgende patiënten met veneuze trombose (1).
Literatuur
go back to reference Heijboer H, Brandjes DP, Buller HR, Sturk A, Cate JW ten. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Eng J Med 1990; 323: 1512-16. Heijboer H, Brandjes DP, Buller HR, Sturk A, Cate JW ten. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Eng J Med 1990; 323: 1512-16.
go back to reference Lane DA, Ireland H, Olds RJ, Thein SL, Perry DJ, Aiach M. Antithrombin III: a database of mutations. Thromb Haemost 1991; 66: 657-61. Lane DA, Ireland H, Olds RJ, Thein SL, Perry DJ, Aiach M. Antithrombin III: a database of mutations. Thromb Haemost 1991; 66: 657-61.
go back to reference Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-12. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-12.
go back to reference Friederich PW, Sanson BJ, Simioni P, et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Int Med 1996; 125: 955-60. Friederich PW, Sanson BJ, Simioni P, et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Int Med 1996; 125: 955-60.
go back to reference Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, et al. The incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202. Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, et al. The incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81: 198-202.
go back to reference Sanson BJ, Simioni P, Prins MH, on behalf of the TACT-study group. The incidence of venous thromboembolism in asymptomatic carriers of a marker of thrombophilia. Blood 1997; 90: 153a Abstract. Sanson BJ, Simioni P, Prins MH, on behalf of the TACT-study group. The incidence of venous thromboembolism in asymptomatic carriers of a marker of thrombophilia. Blood 1997; 90: 153a Abstract.
go back to reference Belt AGM van den, Prins MH, Huisman MV, Hirsh J. Familial Thrombophilia: A Review Analysis. Clin Appl Thromb Hemost 1996; 2: 227-36. Belt AGM van den, Prins MH, Huisman MV, Hirsh J. Familial Thrombophilia: A Review Analysis. Clin Appl Thromb Hemost 1996; 2: 227-36.
go back to reference Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Int Med 1996; 125: 1-7. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Int Med 1996; 125: 1-7.
go back to reference De Stefano V, Leone G, Mastrangelo S, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 pa tients with congenital deficiency of an tithrombin III, protein C, protein S. Thromb Haemost 1994; 72: 352-58. De Stefano V, Leone G, Mastrangelo S, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 pa tients with congenital deficiency of an tithrombin III, protein C, protein S. Thromb Haemost 1994; 72: 352-58.
go back to reference Belt AGM van den, Sanson BJ, Simioni P, et al. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Int Med 1997; 157: 2227-32. Belt AGM van den, Sanson BJ, Simioni P, et al. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Int Med 1997; 157: 2227-32.
go back to reference Meer FJ van der, Rosendaal FR, Vandenbroucke JP, Briët E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Int Med 1993; 153: 1557-62. Meer FJ van der, Rosendaal FR, Vandenbroucke JP, Briët E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Int Med 1993; 153: 1557-62.
Metagegevens
Titel
Is er een indicatie voor levenslange antistollingstherapie bij verlaagde (familiaire) antitrombine III-activiteit?
Auteurs
S. Middeldorp
Prof.Dr. E. Briët
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_1228